Bivalent HPV vaccine

This page covers all Bivalent HPV vaccine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting HPV types 16 and 18 L1 capsid protein.

Targets

HPV types 16 and 18 L1 capsid protein

Marketed (1)

• Cervarix®, GlaxoSmithKline · Cancer Prevention and Research Institute, Italy · Oncology
  Cervarix is a bivalent human papillomavirus (HPV) vaccine that stimulates the immune system to produce antibodies against HPV types 16 and 18, preventing infection and cervical cancer development.

Patent intelligence

• bivalent hpv vaccine patent landscape — aggregated cliff calendar, attackable patents, originator estates